NTRA - Natera Inc Debt to Book Capitalization Ratio

Graphic logo of Natera (NTRA)

Natera, Inc. (NTRA) is a leading player in genetics whose success is based on unique datasets and non-invasive screening. The issuer is expanding its service profile from reproduction to oncology monitoring, thereby minimizing risks. A focus on the US domestic market eliminates external political pressure. The debt-to-market cap ratio on GURU.Markets yields the current status of 0.13, demonstrating the business's financial stability.

Natera Medical (NTRA) - Debts to Book Value from 07/04/2022 to 10/28/2026

Metric breakdowns and analytics for Natera Inc (NTRA)

- price and consensus price forecast:
Price Chart Natera, Inc.|NTRA - Forecast Levels Chart
- market capitalization data:
Market Value Natera Medical|NTRA - Value Adjusted for Debt and Cash
- book capitalization data:
Net Assets per Single Share Natera|NTRA - Total Stockholders' Equity|Market Capitalization to Book Value Ratio natera.com|NTRA - Total Business Assets
- debt and liquidity data:
Total Debt to Equity Ratio Natera, Inc.|NTRA - Long-Term Debt to Capital|Short-Term Debt to Capital Natera Corp|NTRA - Company Total Debt|Debt to Book Value Natera Medical
Analysis of all company metrics:NTRA Natera, Inc.
Product sample of Natera Inc

This metric reflects leverage dynamics, measuring the proportion of borrowed funds relative to equity to assess the business's financial stability. This ratio of debt obligations to balance sheet capital demonstrates how aggressively Natera, Inc. (NTRA) is financing its expansion into the high-margin oncology testing segment, allowing investors to promptly identify a critical increase in debt load amid the company's rapid scaling.

Competitors of Natera, Inc.

Humacyte, Inc. (HUMA) - Debt to Book Capitalization Ratio|seraprognostics.com - Debts to Book Capitalization Ratio